APELLIS PHARMACEUTICALS INC. - COMMON STOCK
30.77
22-November-24 15:44:58
15 minutes delayed
Stocks
+3.02
+10.88%
Today's range
27.71 - 30.99
ISIN
N/A
Source
NASDAQ
-
Apellis Pharmaceuticals to Host a Fireside Chat at the Jefferies London Healthcare Conference
12 Nov 2024 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
05 Nov 2024 06:05:00 By Nasdaq GlobeNewswire
-
26 Oct 2024 13:00:00 By Nasdaq GlobeNewswire
-
22 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
16 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2024 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
25 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
20 Sep 2024 04:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
29 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2024 06:00:01 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Aug 2024 15:05:01 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results
01 Aug 2024 06:05:00 By Nasdaq GlobeNewswire
-
18 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
09 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
28 Jun 2024 05:57:12 By Nasdaq GlobeNewswire
-
10 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
05 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
24 May 2024 09:00:00 By Nasdaq GlobeNewswire
-
14 May 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >